Mangoceuticals Inc.

NASDAQ: MGRX · Real-Time Price · USD
1.59
0.01 (0.63%)
At close: Aug 15, 2025, 1:09 PM

Mangoceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-8.71M -9.21M -2M -17.7K
Depreciation & Amortization
731.47K 24.89K 3.86K n/a
Stock-Based Compensation
248.68K 624.46K 234.09K n/a
Other Working Capital
-36.36K -65.58K -14.81K n/a
Other Non-Cash Items
2.2M 1.52M 546.54K 181.00
Deferred Income Tax
n/a n/a -151.82K n/a
Change in Working Capital
660.38K 41.51K 18.87K n/a
Operating Cash Flow
-4.86M -7M -1.35M -17.52K
Capital Expenditures
n/a -3.52K -43.1K n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
65K n/a n/a n/a
Investing Cash Flow
65K -3.52K -43.1K n/a
Debt Repayment
150K -167.46K 49.93K n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a 1.02M n/a n/a
Financial Cash Flow
4.13M 7.06M 2.05M 160.28K
Net Cash Flow
-680.35K 56.15K 660.31K 22.55K
Free Cash Flow
-4.86M -7M -1.39M -17.52K